<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1561-3194</journal-id>
<journal-title><![CDATA[Revista de Ciencias Médicas de Pinar del Río]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Ciencias Médicas]]></abbrev-journal-title>
<issn>1561-3194</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1561-31942020000400006</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Analgesia multidimensional para los pacientes en estadio terminal por cáncer de páncreas]]></article-title>
<article-title xml:lang="en"><![CDATA[Multidimensional analgesia for terminal stage patients with pancreatic cancer]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Garcia]]></surname>
<given-names><![CDATA[Omar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernández Martínez]]></surname>
<given-names><![CDATA[María Julia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valdés Miranda]]></surname>
<given-names><![CDATA[José Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Pinar del Río Hospital General Docente Abel Santamaría Cuadrado ]]></institution>
<addr-line><![CDATA[Pinar del Río ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2020</year>
</pub-date>
<volume>24</volume>
<numero>4</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1561-31942020000400006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1561-31942020000400006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1561-31942020000400006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  el cáncer es la segunda causa de muerte en el mundo; los tumores del sistema digestivo ocupan el segundo lugar y según localización los de páncreas poseen la menor tasa de supervivencia.  Objetivo:  evaluar la efectividad de la analgesia multidimensional para los pacientes en estadio terminal por cáncer de páncreas.  Métodos: se realizó un estudio cuasiexperimental, comparativo, prospectivo y longitudinal en pacientes con dolor por tumor de páncreas en etapa final de su enfermedad, en el Hospital Abel Santamaria Cuadrado desde noviembre 2016 a julio 2019. Se incluyeron todos los pacientes con dolor por tumor de páncreas en estadio terminal, se conformaron tres grupos de acuerdo con el método de analgesia empleado; Grupo I (n=10) analgesia multimodal, Grupo II (n=10) analgesia multidimensional y Grupo III (n=3) esquema de analgesia de la Organización Mundial de la Salud, se evaluó calidad de la analgesia, la necesidad de dosis de rescate y uso de morfina, se compararon los métodos y se determinó la supervivencia.  Resultados:  la calidad de la analgesia fue mayor en los pacientes del grupo II, en igual grupo no fue necesario el uso de morfina hasta el 7mo mes y en solo dos pacientes, (p=0,00) no hubo diferencias en las tasas de supervivencia.  Conclusiones:  el enfoque multidimensional de la analgesia, donde se incluya al individuo como ser biopsicosocial y a la familia, logra mayor calidad de la analgesia. El método empleado para el alivio del dolor no influye en la supervivencia.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  cancer is the second leading cause of death in the world; the tumors of the digestive system occupy the second place and according to itslocation, those in the pancreas have the lowest survival rate.  Objective:  to assess the effectiveness of multidimensional analgesia for patients in terminal stage due to pancreatic cancer.  Methods:  a quasi-experimental, comparative, prospective and longitudinal study was conducted in patients with pain due to pancreatic tumor in terminal stage at Abel Santamaria Cuadrado General Teaching Hospital from November 2016 to July 2019; all patients with pain due topancreatictumor were included. In the terminal stage of pancreatic cancer, three (3) groups were completed according to the analgesia method applied; Group I (n = 10) multimodal analgesia, Group II (n = 10) multidimensional analgesia and Group III (n = 3) following WHO analgesia scheme, analgesia quality, and the need for rescue dose and application of morphine, the methods were compared and survival rate was determined.  Results:  the quality of analgesia was higher in patients from group II, in the same group the application of morphine was not required until the 7th month and in only two patients (p = 0.00), there were no differences in the rates of survival.  Conclusions:  the multidimensional approach to analgesia, where the individual is included as a biopsychosocial being and the family achieves greater quality of analgesia, the method applied for pain relief does not influence on survival.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[CÁNCER]]></kwd>
<kwd lng="es"><![CDATA[ANALGESIA MULTIDIMENSIONAL]]></kwd>
<kwd lng="es"><![CDATA[ESTADIO FINAL]]></kwd>
<kwd lng="es"><![CDATA[TUMOR DE PÁNCREAS]]></kwd>
<kwd lng="en"><![CDATA[CANCER]]></kwd>
<kwd lng="en"><![CDATA[MULTIDIMENSIONAL ANALGESIA]]></kwd>
<kwd lng="en"><![CDATA[FINAL STAGE]]></kwd>
<kwd lng="en"><![CDATA[PANCREAS TUMOR]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<source><![CDATA[Datos Y Cifras Sobre El Cáncer]]></source>
<year>2020</year>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<source><![CDATA[Anuario Estadístico de Salud 2017]]></source>
<year>2018</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Salud Pública, Dirección de Registros Médicos y Estadísticas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<source><![CDATA[Health professional version]]></source>
<year>2017</year>
<publisher-name><![CDATA[National Cancer Institute. Cancer pain (PDQ)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De los Reyes-Pacheco]]></surname>
<given-names><![CDATA[VA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manejo intervencionista del dolor en el paciente oncologico]]></article-title>
<source><![CDATA[Revista Mexicana de Anestesiología]]></source>
<year>2019</year>
<volume>42</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Granados]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Arrieta Rodríguez]]></surname>
<given-names><![CDATA[OG]]></given-names>
</name>
<name>
<surname><![CDATA[Hinojosa Gómez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Tratamiento del cáncer. Oncología Médica, Quirúrgica y Radioterapia]]></source>
<year>2016</year>
<edition>1</edition>
<publisher-name><![CDATA[Axon]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fallon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Giusti]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Aielli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines.]]></article-title>
<source><![CDATA[Ann Oncol]]></source>
<year>2018</year>
<volume>29</volume>
<numero>^s4</numero>
<issue>^s4</issue>
<supplement>4</supplement>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laborí Quesada]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Quesada Marrero]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Aramís Puig Rodríguez]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La familia en los cuidados paliativos del enfermo con cáncer avanzado.]]></article-title>
<source><![CDATA[Rev Elect Zoilo Marinello]]></source>
<year>2015</year>
<volume>40</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guerrero Alcedo]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Ramsés Prepo Serrano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gregorio Loyo Álvarez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autotrascendencia, ansiedad y depresión en pacientes con cáncer en tratamiento. Barquisimeto]]></article-title>
<source><![CDATA[Rev Habanera de Ciencias Médicas]]></source>
<year>2015</year>
<volume>15</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schumacher]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Archbold]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of caregiving demand, mutuality, and preparedness on family caregiver outcomes during cancer treatment.]]></article-title>
<source><![CDATA[Oncol Nurs Forum]]></source>
<year>2008</year>
<volume>35</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<source><![CDATA[El cáncer, tratamientos secundarios y efectos; El dolor y el cáncer. Versión para profesionales de salud]]></source>
<year>2018</year>
<publisher-name><![CDATA[National Cancer Institute]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caraceni]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cherny]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Fainsinger]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pain measurement tools and methods in clinical research in palliative care: recommendations of an expert working group of the European Association of Palliative Care]]></article-title>
<source><![CDATA[J Pain Symptom Manage]]></source>
<year>2002</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bandieri]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ripamonti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Randomized trial of lowdose morphine versus weak opioids in moderate cancer pain]]></article-title>
<source><![CDATA[J Clin Oncol]]></source>
<year>2016</year>
<volume>34</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[DeVita]]></surname>
<given-names><![CDATA[Hellman and Rosenberg&#8217;s]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer Principles &amp; Practice of Oncology]]></source>
<year>2019</year>
<edition>11</edition>
<page-range>1459-98</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Wolters Kluwer Health]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<source><![CDATA[Pronóstico y supervivencia]]></source>
<year>2016</year>
<publisher-name><![CDATA[Asociación del cáncer de páncreas]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
